Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: An NYGOG and ECOG study Article

Hochster, HS, Plimack, ER, Mandeli, J et al. (2006). Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: An NYGOG and ECOG study . GYNECOLOGIC ONCOLOGY, 100(2), 324-329. 10.1016/j.ygyno.2005.08.059

cited authors

  • Hochster, HS; Plimack, ER; Mandeli, J; Wadler, S; Runowicz, C; Goldberg, G; Speyer, J; Wallach, R; Muggia, F

sustainable development goals

authors

publication date

  • February 1, 2006

webpage

published in

keywords

  • 2ND-LINE TREATMENT
  • CARBOPLATIN
  • CHEMOTHERAPY
  • COMBINATION
  • CYCLOPHOSPHAMIDE
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • PACLITAXEL
  • PHASE-II
  • RECURRENT
  • STAGE-III
  • Science & Technology
  • TRIAL
  • first-line chemotherapy
  • infusional chemotherapy
  • ovarian cancer
  • platinum
  • topotecan

Location

  • SAN FRANCISCO, CA

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 324

end page

  • 329

volume

  • 100

issue

  • 2